Although IPC (ischaemic preconditioning) is considered as a protective strategy in HI/R (hepatic ischaemia/reperfusion), the mechanisms for this effect have not been fully elucidated. In the present study we investigate whether PPC (pharmacological preconditioning) by transient activation of A1R (adenosine A1 receptor) protects against long-term HI/R and whether the protective effects of IPC depend on A1R activation and whether both preconditionings affect remote organs. Wistar rats underwent IPC and long-term HI/R. Another set of animals were pharmacologically preconditioned with the A1R-agonist CCPA [2-chloro-N6-cyclopentyladenosine; 0.1 mg/kg of body weight, i.p. (intraperitoneally)] 24 h before HI/R. In other groups, rats received an A1R-antagonist, DPCPX (1,3-dipropyl-8-cyclopentylxanthine; 0.1 mg/kg of body weight, i.p.) 24 h before HI/R. Hepatic damage was evaluated by transaminase [AST (aspartate transaminase), ALT (alanine transaminase)] release; inflammation was assessed by hepatic MPO (myeloperoxidase) and serum TNFα (tumour necrosis factor α) and NO; oxidative stress was estimated by MDA (malondialdehyde) and 4-HDA (4-hydroxyalkenals), SOD (superoxide dismutase) activity, GSH and ADA (adenosine deaminase) as adenosine metabolism. Both preconditionings protected liver and lung against HI/R as indicated by the reduction in transaminases, MPO, MDA+4-HDA, NO, TNFα and ADA activity as compared with HI/R (P<0.05). However, pre-treatment with DPCPX abolished the protective effects of IPC and PPC. Preconditionings induced a significant increase in hepatic MnSOD (manganese SOD) activity and NO generation compared with the sham group, and this activity was abolished by DPCPX pre-treatment. A1R activation induced hepatic delayed preconditioning and blockade of A1R abolished hepatic IPC. IPC, as well as PPC, were able to prevent lung damage. These protective effects are associated with a reduction in oxidative stress, inflammation and endogenous antioxidant preservation.
Skip Nav Destination
Article navigation
July 2008
-
Cover Image
Cover Image
- PDF Icon PDF LinkTable of Contents
Research Article|
June 12 2008
Ischaemic and pharmacological preconditionings protect liver via adenosine and redox status following hepatic ischaemia/reperfusion in rats
Hussam H. Ajamieh;
*Department of Medicine II, Klinikum Grosshadern, University of Munich, Munich, D-81377 Germany
†Center of Studies for Research and Biological Evaluation (CEIEB-IFAL-UH), University of Havana, Havana City, Cuba
Correspondence: Dr Hussam H. Ajamieh (email [email protected]).
Search for other works by this author on:
Eduardo Candelario-Jalil;
Eduardo Candelario-Jalil
‡Department of Neurology, University of New Mexico, Health Sciences Center MSC10 5620, 915 Camino de Salud NE, Albuquerque, NM 87131-0001, U.S.A.
Search for other works by this author on:
Olga Sonia León Fernández;
Olga Sonia León Fernández
†Center of Studies for Research and Biological Evaluation (CEIEB-IFAL-UH), University of Havana, Havana City, Cuba
Search for other works by this author on:
Alexander L Gerbes
Alexander L Gerbes
§Department of Medicine II, Klinikum Grosshadern, University of Munich, Munich, D-81377 Germany
Search for other works by this author on:
Publisher: Portland Press Ltd
Received:
November 23 2007
Revision Received:
February 06 2008
Accepted:
February 29 2008
Accepted Manuscript online:
February 29 2008
Online ISSN: 1470-8736
Print ISSN: 0143-5221
© The Authors Journal compilation © 2008 Biochemical Society
2008
Clin Sci (Lond) (2008) 115 (2): 69–77.
Article history
Received:
November 23 2007
Revision Received:
February 06 2008
Accepted:
February 29 2008
Accepted Manuscript online:
February 29 2008
Citation
Hussam H. Ajamieh, Eduardo Candelario-Jalil, Olga Sonia León Fernández, Alexander L Gerbes; Ischaemic and pharmacological preconditionings protect liver via adenosine and redox status following hepatic ischaemia/reperfusion in rats. Clin Sci (Lond) 1 July 2008; 115 (2): 69–77. doi: https://doi.org/10.1042/CS20070415
Download citation file:
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Biochemical Society Member Sign in
Sign InSign in via your Institution
Sign in via your InstitutionGet Access To This Article
Open Access for all
We offer compliant routes for all authors from 2025. With library support, there will be no author nor reader charges in 5 journals. Check here |
![]() |